# Gradiant

Gradiant is a Corporate Investor based in Seoul, South Korea.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Seoul, South Korea
- **Region:** Asia
- **Address:** 19th Floor, Samsung-dong Building, 512 Gangnam-gu, Samseong-ro, Seoul, South Korea
- **Founded:** 1997
- **Assets under management:** 407.58 (Altss estimate)
- **Website:** www.gradiant.co.kr
- **LinkedIn:** https://www.linkedin.com/company/gradiant

## Regulatory record

- **Reports private funds:** No

## About

Gradiant was established in 1997 by Ki-Hyung Lee. The firm operates through management of affiliated companies rather than external fund vehicles. Gradiant deploys capital across early-stage venture and expansion investments. Confirmed holdings include Gradiant Bioconvergence, Therapex, Allen Care, Radiwell and Iambic Therapeutics. Positions extend to public equities such as iMarketKorea and PeopleBio. Geographic reach centers on South Korea with additional exposure in the United States. The firm lists 407.58 million USD in assets. It maintains a headquarters at the Icon Samseong building and is developing the Gradiant Technology Park industrial site in Taylor, Texas. Adjacent structures include the KAOS Foundation established by Ki-Hyung Lee to support science education. Ownership remains concentrated with the founding family and select individual shareholders. Capital allocation occurs through direct subsidiary control and selective co-investments rather than broad fund commitments.

## Sectors

- Biotechnology
- E-commerce
- Logistics

## People

- Ki-Hyung Lee — Founder and Chairman
- In-Bong Nam — Co-CEO and Director

## Questions

### Who runs investment decisions at Gradiant?

Ki-Hyung Lee serves as Founder and Chairman. In-Bong Nam acts as Co-CEO and Director.

### Does Gradiant participate in fund commitments or only direct deals?

The firm executes through direct ownership of operating subsidiaries and limited partner positions in biotechnology startups.

### What investment stages does Gradiant typically target?

Activity spans early-stage seed and start-up rounds as well as expansion and late-stage opportunities.

## Related profiles

- [I.U.O.E Local 68](https://altss.com/profile/i-u-o-e-local-68)
- [Dana Pensiun Perkebunan](https://altss.com/profile/dana-pensiun-perkebunan)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/gradiant

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology